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Introduction
Monocytes play a key role in both the systemic and
local progression of rheumatoid arthritis (RA) by produ-
cing molecules that participate to the inflammatory and
catabolic events of disease pathogenesis (1). Recently,
the spleen has been shown to contribute to the regula-
tion of inflammation through monocytes that are able to
exit and rapidly deploy to inflammatory sites (2).
These observations uncover a role for splenic mono-
cytes as a resource exploited by the body to regulate
inflammation. Thus, the engineering of vectors tailored
to selectively target both tissue resident and circulating
monocytes is a promising research track for addressing
the role of specific genes in RA pathogenicity. Several
lines of evidence imply cytosolic phospholipase A2a
(cPLA2a) as a critical enzyme in inflammatory disorders
including RA.
Aim
The present study aimed at examining the effect of the
cPLA2a inhibition within monocytes using RNA inter-
ference in experimental arthritis.
Methods
Mice with collagen-induced arthritis (CIA) were injected
intravenously with a cPLA2a small interfering RNA
(siRNA) sequence formulated with the RPR209120/
DOPE cationic liposome. Clinical course of the joint
inflammation was assessed and the immunological bal-
ance analyzed by measuring T helper cell frequencies
and cytokine expression. Biodistribution studies of
siRNA were performed.
Results
Weekly systemic injections of anti-cPLA2a siRNA-
lipoplexes significantly reduced incidence and severity of
CIA, both in preventive and curative settings, as compared
with control groups. Histological scores of inflammation
and cartilage damage were lowered. The clinical effect was
associated with local inhibition of TNF-a secretion and
lower cPLA2a expression and activity. The siPLA2 lipo-
plexes enabled to trigger in vivo RNAi-mediated gene
silencing of cPLA2a in CD11b
+ cells recovered from the
spleen. While the treatment had no effect on anti-collagen
II antibodies, CII-specific T helper cells producing IFN-g,
but not IL-17, were decreased in draining lymph nodes
cells.
Conclusion
Our findings indicate that systemic RNAi-mediated
cPLA2a gene silencing in CD11b
+ cells results in effec-
tive treatment of CIA, and Th1 but not Th17 suppres-
sion is one of the potential underlying mechanisms.
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